Today: 17 April 2026

Abbott (ABT) stock price steadies after Barclays trims target; Exact Sciences vote is next key date

Abbott (ABT) stock price steadies after Barclays trims target; Exact Sciences vote is next key date

Abbott Laboratories shares edged up 0.1% to $109.43 after Barclays cut its price target to $142 but kept an Overweight rating. Nutrition sales fell 8.9% last quarter, and diagnostics dropped 2.5%. Exact Sciences shareholders will vote February 20 on Abbott’s planned $23 billion takeover. The deal is expected to close in the second quarter of 2026.
Carvana stock ticks higher after-hours as traders size up short report, earnings ahead

Carvana stock ticks higher after-hours as traders size up short report, earnings ahead

Carvana shares rose 1.7% in after-hours trading Monday, closing at $407.83 after a volatile session. The move follows allegations from Gotham City Research that Carvana inflated profits through undisclosed related-party transactions, which the company denies. Analysts at JPMorgan and BTIG questioned the short seller’s claims. Investors await Carvana’s earnings report and call on Feb. 18.
Ondas (ONDS) stock rises after Rotron Aero deal — what investors watch after the bell

Ondas (ONDS) stock rises after Rotron Aero deal — what investors watch after the bell

Ondas Inc. shares rose 3.6% to $10.73 after announcing a deal to acquire UK-based Rotron Aero, pending regulatory approvals. The company will pay with a mix of cash and stock but did not disclose the purchase price or closing timeline. Rotron specializes in expendable attack drones and defense-grade engines. Ondas cited demand for long-range, affordable unmanned systems.
2 February 2026
Lockheed Martin stock price today: LMT edges higher after Taiwan contract and Fujitsu tech pact

Lockheed Martin stock price today: LMT edges higher after Taiwan contract and Fujitsu tech pact

Lockheed Martin shares rose 0.5% to $637.50 Monday after announcing a $328.5 million U.S. contract to supply IRST21 Legion-ES sensors to Taiwan’s Air Force. The company also delivered its first Sentinel A4 radar to the U.S. Army and signed a tech partnership with Fujitsu. Broader defense stocks were mixed as investors weighed Washington’s push for faster weapons production.
Qualcomm stock price edges up as Wall Street trims targets ahead of Feb. 4 earnings

Qualcomm stock price edges up as Wall Street trims targets ahead of Feb. 4 earnings

Qualcomm shares rose 0.5% to $152.32 Monday afternoon, rebounding from earlier lows ahead of its February 4 earnings report. Cantor Fitzgerald cut its price target to $160, with JPMorgan and Bernstein also lowering targets. Investors are focused on the company’s guidance for the March quarter. Analyst C.J. Muse warned of headwinds from weak smartphone demand and changing customer mix.
Eaton stock pops late Monday ahead of ETN earnings: what traders are watching next

Eaton stock pops late Monday ahead of ETN earnings: what traders are watching next

Eaton shares rose 2.4% to $359.68 in late U.S. trading Monday as investors awaited Tuesday’s quarterly earnings and 2026 outlook. The company plans to spin off its Mobility Group, focusing instead on electrification and aerospace. Analysts flagged Mobility’s lower margins as a factor. The earnings release and conference call are scheduled for Tuesday morning.
Adobe stock dips today as Creative Cloud discount clock runs out; March earnings loom

Adobe stock dips today as Creative Cloud discount clock runs out; March earnings loom

Adobe shares fell 0.5% to $291.81 Monday afternoon, lagging a broader market rally. The drop followed news that Adobe’s 40% Creative Cloud Pro discount will end Feb. 2, raising questions about pricing and demand. The company’s next earnings call is scheduled for March 12. The S&P 500 and Nasdaq both advanced, lifted by gains in chipmakers and AI stocks.
GE Aerospace stock price today: Moody’s upgrade and Singapore tech deals lift GE shares

GE Aerospace stock price today: Moody’s upgrade and Singapore tech deals lift GE shares

GE Aerospace shares rose 0.6% to $308.50 after Moody’s upgraded its senior unsecured rating to A2. The company signed a memorandum with Singapore authorities to establish SPAARC, focusing on AI and airspace modernization. CFM International and Airbus also agreed to test open fan engine technology in Singapore. Supply-chain disruptions continue to impact engine makers, according to IATA.
PennyMac Financial Services stock slides again as KBW cuts target and MSR runoff stays in focus

PennyMac Financial Services stock slides again as KBW cuts target and MSR runoff stays in focus

PennyMac Financial (PFSI) fell 5.3% to $94.58 Monday after KBW cut its price target to $115 from $143, citing concerns over faster mortgage prepayments and servicing rights runoff. The stock has dropped 38% since Jan. 29. Fourth-quarter net income was $106.8 million, with servicing segment pretax income plunging to $37.3 million. A law firm has launched a probe into the late-January share plunge.
2 February 2026
Pfizer stock (PFE) edges up ahead of Feb. 3 earnings as obesity pricing shifts and RSV dispute draw focus

Pfizer stock (PFE) edges up ahead of Feb. 3 earnings as obesity pricing shifts and RSV dispute draw focus

Pfizer shares rose 0.3% to $26.51 ahead of fourth-quarter and full-year 2025 results due Feb. 3. Analysts expect adjusted earnings of 57–58 cents per share on $16.7–16.9 billion revenue. Obesity drug price cuts and a UK ruling against Sanofi in an RSV dispute add pressure. Pfizer projects 2026 revenue of $59.5–62.5 billion, factoring in losses from COVID-19 products and patent expirations.
2 February 2026
Coherent (COHR) stock jumps more than 6% — earnings and a Bystronic deal update are in focus

Coherent (COHR) stock jumps more than 6% — earnings and a Bystronic deal update are in focus

Coherent shares jumped over 6% Monday, trading as high as $229.10 after Bystronic confirmed it completed the purchase of Coherent’s Tools for Materials Processing business. The company will report fiscal second-quarter results after markets close Feb. 4. Analysts expect earnings of $1.22 per share on $1.6 billion in revenue. Intraday volatility spiked ahead of the results, with options pricing in a 15% move by Feb. 6.

Stock Market Today

  • Symbotic (SYM) Valuation Shows Mixed Signals Amid Strong Backlog and Cash Flow Models
    April 17, 2026, 4:47 AM EDT. Symbotic (SYM) shares hover near $60.56 after a strong 197% total return over the past year and 19.9% revenue growth. The company boasts a record $22.4 billion backlog, reflecting robust demand for its warehouse automation systems amid rising e-commerce adoption. Analysts' valuation models diverge: a narrative-based fair value of $64.05 suggests the stock is 5.4% undervalued, relying on rapid backlog conversion and margin expansion. In contrast, a discounted cash flow (DCF) model values shares at $47.64, signaling overvaluation based on cash flow projections. This valuation split highlights uncertain assumptions about Symbotic's ability to translate its backlog into sustainable cash earnings, with risks including customer concentration and contract delays.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 17.04.2026

17 April 2026
LIVEMarkets rolling coverageStarted: April 17, 2026, 12:00 AM EDTUpdated: April 17, 2026, 4:47 AM EDT Symbotic (SYM) Valuation Shows Mixed Signals Amid Strong Backlog and Cash Flow Models April 17, 2026, 4:47 AM EDT. Symbotic (SYM) shares hover near $60.56 after a strong 197% total return over the past year and 19.9% revenue growth. The company boasts a record $22.4 billion backlog, reflecting robust demand for its warehouse automation systems amid rising e-commerce adoption. Analysts' valuation models diverge: a narrative-based fair value of $64.05 suggests the stock is 5.4% undervalued, relying on rapid backlog conversion and margin expansion. In contrast,
Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Go toTop